1. Interleukin-2 toxicity;Siegel;J. Clin. Oncol.,1991
2. Clinical effects and toxicity of interleukin-2 in patients with cancer;Lotze;Cancer,1986
3. Interleukin-2 activated human lymphocytes exhibit enhanced adhesion to normal vascular endothelial cells and cause their lysis;Damle;J. Immunol.,1987
4. Toxicity of human recombinant interleukin-2 in the mouse is mediated by interleukin-activated lymphocytes;Anderson,1988
5. Interleukin-2 in cancer therapy;Parkinson;Semin. Oncol.,1988